Academic background&position

data loading...

1. [SCIE] First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers [Journal for ImmunoTherapy of Cancer] - 2026-03-09
2. [SCIE] Prognostic implications of tumour number in intrahepatic cholangiocarcinoma [JHEP Reports] - 2026-02-27
3. [SCIE] Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab [JOURNAL OF HEPATOLOGY] - 2026-02-15
4. [SCIE] Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma [JOURNAL OF HEPATOLOGY] - 2026-01-15
5. [SCIE] Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study [JOURNAL OF HEPATOLOGY] - 2025-09-15